JP2022529845A5 - - Google Patents

Info

Publication number
JP2022529845A5
JP2022529845A5 JP2021563237A JP2021563237A JP2022529845A5 JP 2022529845 A5 JP2022529845 A5 JP 2022529845A5 JP 2021563237 A JP2021563237 A JP 2021563237A JP 2021563237 A JP2021563237 A JP 2021563237A JP 2022529845 A5 JP2022529845 A5 JP 2022529845A5
Authority
JP
Japan
Prior art keywords
compound
isolated
purity
purified form
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021563237A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022529845A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/025142 external-priority patent/WO2020219207A1/en
Publication of JP2022529845A publication Critical patent/JP2022529845A/ja
Publication of JP2022529845A5 publication Critical patent/JP2022529845A5/ja
Pending legal-status Critical Current

Links

JP2021563237A 2019-04-26 2020-03-27 スフィンゴシン1リン酸受容体調節因子 Pending JP2022529845A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962839495P 2019-04-26 2019-04-26
US62/839,495 2019-04-26
PCT/US2020/025142 WO2020219207A1 (en) 2019-04-26 2020-03-27 Sphingosine 1 phosphate receptor modulator

Publications (2)

Publication Number Publication Date
JP2022529845A JP2022529845A (ja) 2022-06-24
JP2022529845A5 true JP2022529845A5 (https=) 2023-03-30

Family

ID=72941745

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021563237A Pending JP2022529845A (ja) 2019-04-26 2020-03-27 スフィンゴシン1リン酸受容体調節因子

Country Status (6)

Country Link
US (1) US20220227722A1 (https=)
EP (1) EP3959204A4 (https=)
JP (1) JP2022529845A (https=)
KR (1) KR20220007065A (https=)
CN (1) CN114008034A (https=)
WO (1) WO2020219207A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021099469A1 (en) * 2019-11-22 2021-05-27 Basf Coatings Gmbh Electrodeposition coating material containing catechol derivatives as anticorrosion agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3782991A1 (en) * 2008-05-14 2021-02-24 The Scripps Research Institute Novel modulators of sphingosine phosphate receptors
MX2012005560A (es) * 2009-11-13 2012-10-05 Receptos Inc Moduladores selectivos del receptor de esfingosina 1 fosfato y metodos de sintesis quiral.
EP3280703A1 (en) * 2015-04-06 2018-02-14 Auspex Pharmaceuticals, Inc. Deuterium-substituted oxadiazoles
EP3621610A1 (en) * 2017-05-08 2020-03-18 Celgene International II Sàrl Sphingosine 1 phosphate receptor agonists for neuroprotection
CA3061201A1 (en) * 2017-06-23 2018-12-27 Enzo Biochem, Inc. Sphingosine pathway modulating compounds for the treatment of cancers
AR116479A1 (es) * 2018-09-25 2021-05-12 Quim Sintetica S A Intermediarios para la síntesis de ozanimod y procedimiento para la preparación del mencionado agonista del receptor de esfingosina-1-fosfato y de dichos intermediarios

Similar Documents

Publication Publication Date Title
JP2024071370A5 (https=)
JP2005523922A5 (https=)
JP2024516371A5 (https=)
JP2023535701A5 (https=)
JP2020169171A5 (https=)
JP2021191784A5 (https=)
JP2013518107A5 (https=)
RU2021139070A (ru) Ингибиторы ERBB/BTK
JP2018524304A5 (https=)
JP2008509953A5 (https=)
JP2020507589A5 (https=)
JP2019526596A5 (https=)
JP2017531619A5 (https=)
JP2004524312A5 (https=)
JP2023534131A5 (https=)
JP2007524683A5 (https=)
JP2010090149A5 (https=)
JP2020097577A5 (https=)
JP2013514980A5 (https=)
KR900003151A (ko) 화합물
JP2012525437A5 (https=)
JP2020128426A5 (https=)
JP2023022236A5 (https=)
JP2022529845A5 (https=)
JP2020516616A5 (https=)